Aldosteronism Treatments Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Aldosteronism Treatments Market is expected to gain exponential industry growth over the given forecast period of 2022-2028.

Aldosteronism is a type of hormonal disorder that results from an imbalance of aldosterone and further leads to high blood pressure. In aldosteronism, aldosterone is produced in excess by the adrenal glands in excess of the body’s normal needs. This increases sodium levels and lowers potassium levels in the body. High sodium levels in the blood lead to increased blood volume and ultimately high blood pressure. There are different types of aldosteronism: primary aldosteronism (Con’s syndrome) and secondary aldosteronism. Primary aldosteronism is a defect in the adrenal gland itself that releases too much aldosterone. In secondary aldosteronism, on the other hand, aldosterone is released due to abnormal body functions or genetic defects and other medical disorders. Most cases of primary aldosteronism are caused by noncancerous tumors of the adrenal glands.

Market Segments

Based on treatment type

• Surgical aldosteronism treatment
• Endocrine surgery
• Adrenalectomy
• Non-Surgical aldosteronism treatment
• Palliative care
• Drugs
• Mineralocorticoid receptor antagonists
• Calcium-channel blockers
• Potassium sparring diuretics

Based on end users

• Hospitals
• Ambulatory Surgical Centers
• Others

Key Players

The key players in the market are: Pfizer Inc., Allergan plc., GE Healthcare, Novartis AG, Teva Pharmaceutical Industries Ltd., Accord Healthcare and Sun Pharmaceutical Industries Ltd, amongst others

Scope of the Report

The research study analyzes the global Aldosteronism Treatments industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Aldosteronism Treatments Market Report

1. What was the Aldosteronism Treatments Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Aldosteronism Treatments Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Aldosteronism Treatments Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.